Showing results (641-650 of 2,341) with videos related to

Sort By:
Pageof 235
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 25, 2022
Comprehensive Molecular Profiling of Oncocytic Salivary Gland MalignanciesDaniel J Zaccarini, Abirami Sivapiragasam, Ethan Sokol, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 7, 2017
Microsatellite Instability: A Predictive Biomarker for Cancer ImmunotherapyLiisa Chang, Minna Chang, Hanna M Chang, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 1, 2017
An Epithelioid Gastrointestinal Stromal Tumor of the Stomach With Strong Expression of Keratin: Clinicopathologic Correlation and Follow-up Post-Imatinib TherapyNick Baniak, Lawrence Lee, Chen Zhou, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 1, 2017
Prostate Ductal AdenocarcinomaAli Amin
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 1, 2017
Napsin-A, a Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian CarcinomasHanan A Alshenawy, Dina A Radi
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 1, 2017
A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic TumorsSylvia Redon, Briac Guibourg, Matthieu Talagas, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 1, 2017
Detection of Loss of Heterozygosity (LOH) Using Circulating Cell-free DNA (cfDNA) by Fluorescence-based Multiplex PCR for Identification of Patients With Prostate CancerS-Maryam Seyedolmohadessin, Mohammad T Akbari, Zahra Nourmohammadi, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 15, 2021
mTOR Pathway Activation Assessed by Immunohistochemistry in Cervical Biopsies of HPV-associated Endocervical Adenocarcinomas (HPVA): Correlation With Silva Invasion PatternsSheila Segura, Simona Stolnicu, Monica Boros, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 22, 2021
PD-L1 Expression Harmonization in Gastric Cancer Using 22C3 PharmDx and SP263 AssaysTamara Z Dabbagh, Maher A Sughayer
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.
Pageof 235